DualityBio-B (ASX: 09606) announced on June 16, 2026, that it has executed a share repurchase transaction.
The company acquired 53,900 of its own shares on that date, utilizing approximately HK$9.77 million for the buyback.
DualityBio-B (ASX: 09606) announced on June 16, 2026, that it has executed a share repurchase transaction.
The company acquired 53,900 of its own shares on that date, utilizing approximately HK$9.77 million for the buyback.
Comments